Triamterene And Hydrochlorothiazide Tablet
Product Images NDC 63629-2585

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 63629-2585). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Triamterene, one of the active ingredients in the Triamterene and Hydrochlorothiazide tablet, shown as a molecular diagram with labeled nitrogen and amino groups.*

FDA Label Image

Image 2

Chemical structure diagram showing molecular connections between atoms, identified as a component related to the active ingredient triamsone.*

FDA Label Image

Label Image (Lbl636292585)

Label for Triamterene and Hydrochlorothiazide 75 mg / 50 mg tablet by Bryant Ranch Prepack. The label indicates the product is a human prescription oral tablet, comparing it to Maxzide 75/50 mg tablet from Watson Pharma Private Limited. The package contains 30 tablets with an NDC of 63629-2585-1. Additional details include storage instructions (store at 20°-25°C), warnings to stay out of the sun and keep drugs out of children’s reach, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.